ClinicalTrials.Veeva

Menu

An Observational Study on the Quality of Life After Precise Lung Resection Through the Periareolar Incision

F

Fujian Medical University (FJMU)

Status

Enrolling

Conditions

Minimally Invasive Surgery
Surgical Incision

Treatments

Procedure: Type of surgical incision

Study type

Observational

Funder types

Other

Identifiers

NCT06202053
Union-99

Details and patient eligibility

About

With the rapid development of video-assisted thoracoscopic technology, minimally invasive surgery has become the mainstream surgical approach and is widely known to the public. In addition to the pursuit of successful resection, patients seek an improvement in quality of life after surgery, which poses a challenge to surgeons. The surgical quality of uniportal video-assisted thoracoscopic surgery (VATS) is excellent. It has been shown to be superior to conventional VATS in many studies, especially with respect to the length of hospital stay and severity of pain/paresthesia. The rapid increase in the number of patients undergoing uniportal thoracoscopic surgery has led to the gradual widespread use of this technique. Therefore, how to further innovate this technology has become a direction of further research for surgeons. Here, we describe a rare uniportal thoracoscopic procedure through the perirareolar incision that has certain advantages over other uniportal thoracoscopic procedures.

Enrollment

174 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

    1. Be aged 18 years or above; 2. Histological examination confirmed NSCLC;3. Patients undergoing thoracic surgery who met the indication of thoracoscopic surgery; 4. Preoperative assessment of early stage lung cancer without evidence of advanced disease;5. No history of chemotherapy, immunotherapy or radiotherapy; 6. Society of Anesthesiologists (ASA) ⅰ-ⅲ; 7. Volunteer for treatment and sign informed consent.

Exclusion criteria

    1. Prior pulmonary resection or preoperative chemotherapy and/or radiotherapy; 2. There is a risk of thoracotomy or incision change during the operation, and the operation procedure may be complicated, with a large surgical scope (such as the left upper lobe, the whole lung, the right upper middle lung, etc.); 3. Preoperative assessment of poor lung function, unable to tolerate surgery; 4. Combined with other cancers or other terminal diseases; 5. Preoperative pulmonary infection or uncontrolled acute pulmonary disease or acute onset of chronic obstructive pulmonary disease; 6. Patients with severe hypertension (resting systolic/diastolic blood pressure over 180/100 mmHg), intracranial space occupation or intracranial hypertension; 7. Recent brain injury, cerebral infarction, cerebral hemorrhage; People with severe organ dysfunction; Hyperthyroidism; 8. History of angina pectoris, myocardial infarction or heart failure; 9. Thoracoscopic resection of mediastinum, pleura and other non-pulmonary masses; 10. Patients with central nervous system disease; Mental or nervous system disease, cognitive or language dysfunction, unable to cooperate with the completion of the interview; 11. Previous history of chest and back surgery or abnormal surgical anesthesia recovery history.

Trial design

174 participants in 2 patient groups

The experimental group (patients received the periareolar incision)
Treatment:
Procedure: Type of surgical incision
The control group (patients underwent the axillary incision)

Trial contacts and locations

1

Loading...

Central trial contact

Bin Zheng, MD; Chun Chen, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems